U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force. (September 2022)
- Record Type:
- Journal Article
- Title:
- U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force. (September 2022)
- Main Title:
- U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force
- Authors:
- Fukushima, Takahiro
Chubachi, Shotaro
Namkoong, Ho
Otake, Shiro
Nakagawara, Kensuke
Tanaka, Hiromu
Lee, Ho
Morita, Atsuho
Watase, Mayuko
Kusumoto, Tatsuya
Masaki, Katsunori
Kamata, Hirofumi
Ishii, Makoto
Hasegawa, Naoki
Harada, Norihiro
Ueda, Tetsuya
Ueda, Soichiro
Ishiguro, Takashi
Arimura, Ken
Saito, Fukuki
Yoshiyama, Takashi
Nakano, Yasushi
Mutoh, Yoshikazu
Suzuki, Yusuke
Murakami, Koji
Okada, Yukinori
Koike, Ryuji
Kitagawa, Yuko
Kimura, Akinori
Imoto, Seiya
Miyano, Satoru
Ogawa, Seishi
Kanai, Takanori
Fukunaga, Koichi
… (more) - Abstract:
- Highlights: We analyzed the serum uric acid levels and hyperuricemia in patients with COVID-19. High serum uric acid levels were associated with the requirement of invasive mechanical ventilation. Low serum uric acid levels were also associated with the requirement of invasive mechanical ventilation. Abstract: Objectives: This study aimed to identify the relationship between abnormal serum uric acid levels or a history of hyperuricemia and COVID-19 severity in the Japanese population. Methods: We included 1523 patients enrolled in the Japan COVID-19 Task Force cohort between February 2020 and May 2021. We compared the clinical characteristics, including co-morbidities, laboratory findings, and outcomes, particularly invasive mechanical ventilation (IMV), among patients with and without abnormal uric acid levels or a history of hyperuricemia. Results: Patients with high serum uric acid levels were older and had higher body weight and body mass index than those without. In addition, the multiple logistic regression analysis revealed a significant association between high serum uric acid levels or a history of hyperuricemia and an increased risk of IMV (odds ratio [OR] = 1.77; P = 0.03/OR = 1.56; P = 0.04). Moreover, patients with low uric acid levels on admission were also associated significantly with the requirement of IMV (OR = 5.09; P <0.0001). Conclusion: Abnormal serum uric acid levels or a history of hyperuricemia were significantly associated with COVID-19 severityHighlights: We analyzed the serum uric acid levels and hyperuricemia in patients with COVID-19. High serum uric acid levels were associated with the requirement of invasive mechanical ventilation. Low serum uric acid levels were also associated with the requirement of invasive mechanical ventilation. Abstract: Objectives: This study aimed to identify the relationship between abnormal serum uric acid levels or a history of hyperuricemia and COVID-19 severity in the Japanese population. Methods: We included 1523 patients enrolled in the Japan COVID-19 Task Force cohort between February 2020 and May 2021. We compared the clinical characteristics, including co-morbidities, laboratory findings, and outcomes, particularly invasive mechanical ventilation (IMV), among patients with and without abnormal uric acid levels or a history of hyperuricemia. Results: Patients with high serum uric acid levels were older and had higher body weight and body mass index than those without. In addition, the multiple logistic regression analysis revealed a significant association between high serum uric acid levels or a history of hyperuricemia and an increased risk of IMV (odds ratio [OR] = 1.77; P = 0.03/OR = 1.56; P = 0.04). Moreover, patients with low uric acid levels on admission were also associated significantly with the requirement of IMV (OR = 5.09; P <0.0001). Conclusion: Abnormal serum uric acid levels or a history of hyperuricemia were significantly associated with COVID-19 severity in the Japanese cohort. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 122(2022)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 122(2022)
- Issue Display:
- Volume 122, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 122
- Issue:
- 2022
- Issue Sort Value:
- 2022-0122-2022-0000
- Page Start:
- 747
- Page End:
- 754
- Publication Date:
- 2022-09
- Subjects:
- COVID-19 -- Hyperuricemia -- Hypouricemia -- High serum uric acid -- Low serum uric acid -- Respiratory care -- Severity
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2022.07.014 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23290.xml